Neuro-Ophthalmic Manifestations of Immunotherapy Toxicity
Seminars in Neurology · 2026-08-13
DOI: 10.1055/a-2928-7527 ↗Abstract
AbstractApproximately half of the brain subsumes visual function, so neurologic toxicities of immunotherapy medications may frequently manifest with visual symptoms. As the use of immunotherapeutic medicines proliferates for a broader array of indications, neuro-ophthalmologists in clinical practice may increasingly be referred patients with visual symptoms that result. In this review, we discuss the spectrum of neuro-ophthalmic manifestations of immunotherapy toxicity with a broad review of the literature. Both immune checkpoint inhibitors and chimeric antigen receptor T cell therapies are discussed.
EUVIMED